MoU for deepening cooperation & peace as enshrined in teachings of Buddha (See 'Corp Brief') Reddy launches Website to strengthen Non-Ferrous Metal Recycling Ecosystem (See 'Corp Brief') C-DOT & CSIR-NPL sign MoU for research in Classical & Quantum Communications (See 'Corp Brief') SARFAESI - provisions of Section 14 of the Act mandatorily require DM to consider an application filed u/s 14 of the Act, within 30 days' time: HC (See 'Legal Desk') ECI crosses milestone of training over 2,300 field-level election functionaries (See 'Corp Brief') Central Council for Research in Ayurvedic Sciences revives 2 rare Ayurvedic manuscripts (See 'Corp Brief') IBC - Mere stamping of tax invoices at site office only indicates receipt and doesn't imply acceptance by Corporate Debtor (CD) that there was no pre-existing dispute with respect to quantum of amount payable by CD to Operational Creditor: NCLAT (See 'Legal Desk') PM Modi invites PM Starmer to visit India (See 'Corp Brief') India set to welcome 1800+ global delegates at Yashobhoomi for Space Conference (See 'Corp Brief') Insolvency and Bankruptcy Code- Mr. Kuldeep Verma had charged fees and expenses exceeding regulatory limits and these charges were not supported by requisite approvals : IBBI (See 'Legal Desk') Rijiju meets President of Vietnam Luong Cuong (See 'Corp Brief') IBC - Mr. Anil Kumar Mittal's failure to actively engage and expedite withdrawal process has resulted undue delays in withdrawal process : IBBI (See 'Legal Desk') DFS Secy reviews performance of RRBs (See 'Corp Brief') MoS visits Eastern Coalfields Limited (See 'Corp Brief') BIMSTEC and global experts meet to shape Ethical, Inclusive AI Standards (See 'Corp Brief') IBC - Proceedings u/s 138 of N I Act for dishnonour of cheque can't continue against individuals once moratorium u/s 14 of IBC is in effect: HC (See 'Legal Desk') MICE tourism is recognized as key driver for economic growth (See 'Corp Brief') Prakash Magdum assumes charge as Managing Director, NFDC (See 'Corp Brief') MoS calls for AI-led innovations (See 'Corp Brief') A&C - Procedural order given by Arbitral Tribunal, such as rejecting application seeking impleadment of party, does not qualify as interim award: HC (See 'Legal Desk') A Landmark Ruling Reshaping the IBC Framework (See CORP EINSICHT) APEDA calls stakeholders for Chintan Shivir (See 'Corp Brief') MoS for Coal and Mines reviews performance of CMPDI (See 'Corp Brief') A&C - Once arbitral tribunal is constituted, all jurisdictional and factual issues including status of non-signatories should be resolved by tribunal, not by courts, except under limited scope of review permitted by Sec 34: SC (See 'Legal Desk') WAVES as platform amplifies creative synergy between global and Indian storytellers: Co-CEO of Netflix (See 'Corp Brief') 'Driving Innovation with IP' workshop held at IISc (See 'Corp Brief') IBC - PMLA being Public Law, NCLAT did not have any power or jurisdiction to review decision of Statutory Authority under PMLA: SC (See 'Legal Desk') IICT launches strategic collaborations with Industry Leaders (See 'Corp Brief') Trade Mark Act - Defendants are trying to ruin goodwill established by plaintiffs in their CHOTIWALA trademarks and artistic works : HC (See 'Legal Desk') Mandaviya inaugurates Khelo India Multipurpose Hall in Arunachal (See 'Corp Brief') PMLA - Insolvency and Bankruptcy Code, 2016 does not affect proceedings under Prevention of Money Laundering Act, 2002 : TRIBUNAL (See 'Legal Desk')

Print

Central Council for Research in Ayurvedic Sciences revives 2 rare Ayurvedic manuscripts

Published: May 08, 2025

By TIOLCorplaws News Service

NEW DELHI, MAY 08, 2025: IN a significant stride toward preserving India's rich legacy in traditional medicine, the Central Council for Research in Ayurvedic Sciences (CCRAS), under the Ministry of Ayush, has revived two rare and significant Ayurvedic manuscripts-Dravyaratnakara Nighantu and Dravyanamakara Nighantu.

The publications are unveiled during an event organised by the RRAP Central Ayurveda Research Institute in Mumbai. The event was graced by Prof. Vd. Rabinarayan Acharya, Director General, CCRAS, New Delhi, who also delivered the keynote address highlighting the 'Activities of CCRAS, Ministry of Ayush', in research, digitisation, and revival of traditional Ayurvedic literature.

The manuscripts were critically edited and translated by renowned manuscriptologist and veteran Ayurveda expert, Dr. Sadanand D. Kamat of Mumbai. The release ceremony saw the presence of dignitaries, including Shri Ranjit Puranik, President, Ayurvidya Prasarak Mandal and Managing Director, Shri Dhootapeshwar Limited; Dr. Ravi More, Principal, Ayurveda Mahavidyalaya, Sion; Dr. Shyam Nabar and Dr. Ashanand Sawant from Ayurvidya Prasarak Mandal; and Dr. R. Govind Reddy, Assistant Director (Ayu), CARI, Mumbai.

Speaking on the occasion, Prof. Vd. Rabinarayan Acharya emphasised the importance of such revivals in bridging India's ancient wisdom with contemporary research frameworks. He said that "These texts are not just historical artefacts-they are living knowledge systems that can transform contemporary healthcare approaches when studied and applied thoughtfully".

These critical editions are expected to serve as invaluable resources for students, researchers, academicians, and Ayurveda practitioners, further inspiring scholarly exploration and deeper engagement with India's classical medical literature.

About the Manuscripts

Dravyaratnakara Nighantu:

Authored by Mudgala Pandita in 1480 AD, this previously unpublished lexicon consists of eighteen chapters offering in-depth knowledge on drug synonyms, therapeutic actions, and medicinal properties. A widely referenced text in Maharashtra until the 19th century, it draws from classical Nighantus like Dhanvantari and Raja Nighantu while documenting numerous novel medicinal substances from plant, mineral, and animal origins. This critical edition, revived by Dr. S. D. Kamat, is a monumental contribution to Dravyaguna and allied Ayurvedic disciplines.

Dravyanamakara Nighantu:

Attributed to Bhisma Vaidya, this unique work serves as a standalone appendix to the Dhanvantari Nighantu, focusing exclusively on homonyms of drug and plant names-a complex area of study vital to Ayurveda. Encompassing 182 verses and two colophon verses, the text has been meticulously edited and commented upon by Dr. Kamat, enhancing its utility for scholars of Rasashastra, Bhaishajya Kalpana, and classical Ayurvedic pharmacology.

Dr. Kamat, known for his authoritative work on Saraswati Nighantu, Bhavaprakasha Nighantu, and Dhanvantari Nighantu, once again brings his deep scholarship and commitment to preserving India's Ayurvedic heritage.

These critical editions are more than scholarly achievements; they are beacons for future Ayurvedic practitioners, researchers, and educators. By digitising, editing, and interpreting these works, CCRAS and its collaborators are not only safeguarding literary treasures but also enriching India's traditional healthcare system with validated ancient insights.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.